Joanna Chorostowska‐Wynimko

Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)

Noel G. McElvaney, Jonathan Burdon, Mark Holmes et al. · The Lancet Respiratory Medicine · 2016 · 191 citations · Full text

Open-label Extension Trial, Long-term Efficacy, Immunology +2

Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease

Adam Szpechciński, Joanna Chorostowska‐Wynimko, Radosław Struniawski et al. · British Journal of Cancer · 2015 · 149 citations · Full text

Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and Noncarriers

Carolin V. Schneider, Karim Hamesch, Mattias Mandorfer et al. · Gastroenterology · 2020 · 92 citations · Full text

Allelic Variant, Hepatology, Genotype-phenotype Association +12

Bacterial Immunostimulants—Mechanism of Action and Clinical Application in Respiratory Diseases

Adriana Roży, Joanna Chorostowska‐Wynimko · Advances in respiratory medicine · 2008 · 77 citations · Full text

Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiency

Malin Fromme, Carolin V. Schneider, Vítor Magno Pereira et al. · Gut · 2021 · 68 citations · Full text